Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer
Constantinos Harkos1, Andreas G Hadjigeorgiou1, Chrysovalantis Voutouri1
1Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.
Abstract:
Mathematical modelling has proven to be a valuable tool in predicting the delivery and efficacy of molecular, antibody-based, nano and cellular therapy in solid tumours. Mathematical models based on our understanding of the biological processes at subcellular, cellular and tissue level are known as mechanistic models that, in turn, are divided into continuous and discrete models. Continuous models are further divided into lumped parameter models - for describing the temporal distribution of medicine in tumours and normal organs - and distributed parameter models - for studying the spatiotemporal distribution of therapy in tumours. Discrete models capture interactions at the cellular and subcellular levels. Collectively, these models are useful for optimizing the delivery and efficacy of molecular, nanoscale and cellular therapy in tumours by incorporating the biological characteristics of tumours, the physicochemical properties of drugs, the interactions among drugs, cancer cells and various components of the tumour microenvironment, and for enabling patient-specific predictions when combined with medical imaging. Artificial intelligence-based methods, such as machine learning, have ushered in a new era in oncology. These data-driven approaches complement mechanistic models and have immense potential for improving cancer detection, treatment and drug discovery. Here we review these diverse approaches and suggest ways to combine mechanistic and artificial intelligence-based models to further improve patient treatment outcomes.
Insights
Mathematical models aid in predicting cancer therapy delivery and effectiveness. Combining these mechanistic models with artificial intelligence (AI) shows promise for enhancing patient treatment outcomes in oncology.
Area of Science:
- Oncology
- Mathematical Biology
- Computational Science
Background:
- Mathematical modeling is crucial for predicting the delivery and efficacy of various cancer therapies in solid tumors.
- Mechanistic models, encompassing continuous (lumped and distributed parameter) and discrete types, are based on biological understanding at multiple levels.
- These models integrate tumor biology, drug properties, and microenvironment interactions for optimized therapy and patient-specific predictions.
Purpose of the Study:
- To review diverse mathematical modeling approaches for cancer therapy.
- To explore the role of artificial intelligence (AI) and machine learning (ML) in oncology.
- To suggest synergistic combinations of mechanistic and AI-based models for improved patient outcomes.
Main Methods:
- Review of mechanistic mathematical models (continuous and discrete) for drug delivery and efficacy prediction.
- Discussion of artificial intelligence (AI) and machine learning (ML) applications in cancer research.
- Exploration of integrating mechanistic and AI-driven approaches.
Main Results:
- Mechanistic models provide insights into therapy delivery and efficacy by considering biological and drug properties.
- AI and ML offer complementary data-driven approaches with potential in cancer detection, treatment, and drug discovery.
- Combined mechanistic and AI models hold significant potential for personalized cancer treatment.
Conclusions:
- Mathematical modeling is essential for optimizing molecular, nano, and cellular therapies in solid tumors.
- AI and ML represent a paradigm shift in oncology, complementing traditional modeling.
- Integrating mechanistic and AI models is a promising strategy to advance cancer patient care and treatment effectiveness.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

